Answers are grounded in this paper and cite their sources.
Because of a warning from the FDA, 23andMe has stopped marketing its personal genome service. Now, a dialogue about key issues in genomic testing could result in clear standards for the industry, including requirements for informed consent and disclosure of results.
No takes yet. Share an insight, caveat, or question.
Annas et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: